Ye Byoung Seok, Jang Eun Young, Kim Seong Yoon, Kim Eun-Joo, Park Sun Ah, Lee Yunhwan, Hong Chang Hyung, Choi Seong Hye, Yoon Bora, Yoon Soo Jin, Na Hae Ri, Lee Jae-Hong, Jeong Jee H, Kim Hee Jin, Na Duk L, Seo Sang Won
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Alzheimers Dis. 2016;49(2):483-91. doi: 10.3233/JAD-150556.
We investigated the influence of body mass index (BMI) status at baseline and changes in BMI over a follow-up period on the development of dementia in amnestic mild cognitive impairment (aMCI) patients.
The longitudinal data of 747 aMCI patients were used to investigate the relationships among baseline BMI status, subsequent changes in BMI (median follow-up duration: 1.6 years, interquartile range: 1.0-2.3 years), and risk of progression to probable Alzheimer's disease dementia (pADD). The aMCI patients were classified into underweight, normal weight, overweight, and obese subgroups, and further categorized into increased BMI, stable BMI, and decreased BMI subgroups during follow-up using a 4% mean annual change in BMI cut-off value.
Compared to the normal weight group, the underweight group had a higher risk of pADD (hazard ratio [HR]: 1.89, 95% confidence interval [CI]: 1.07-3.37) while the obese group had a lower risk (HR: 0.70, 95% CI: 0.49-0.999). After controllingfor baseline BMI status, the decreased BMI (HR: 2.29, 95% CI: 1.41-3.72) and increased BMI (HR: 3.96, 95% CI: 2.62-6.00) groups were at increased risk of progression to pADD.
Our findings suggested that underweight at baseline was associated with a higher risk of progression to pADD, while obesity at baseline predicted a lower risk. Furthermore, significant changes in BMI during the follow-up period reflected an increased risk of progression to pADD, regardless of BMI status at baseline.
我们研究了遗忘型轻度认知障碍(aMCI)患者基线时的体重指数(BMI)状态以及随访期间BMI的变化对痴呆症发生发展的影响。
使用747例aMCI患者的纵向数据来研究基线BMI状态、随后BMI的变化(中位随访时间:1.6年,四分位间距:1.0 - 2.3年)与进展为可能的阿尔茨海默病痴呆(pADD)风险之间的关系。将aMCI患者分为体重过轻、正常体重、超重和肥胖亚组,并在随访期间根据BMI年平均变化4%的截断值进一步分为BMI增加、BMI稳定和BMI降低亚组。
与正常体重组相比,体重过轻组发生pADD的风险更高(风险比[HR]:1.89,95%置信区间[CI]:1.07 - 3.37),而肥胖组风险较低(HR:0.70,95%CI:0.49 - 0.999)。在控制基线BMI状态后,BMI降低组(HR:2.29,95%CI:1.41 - 3.72)和BMI增加组(HR:3.96,95%CI:2.62 - 6.00)进展为pADD的风险增加。
我们的研究结果表明,基线体重过轻与进展为pADD的较高风险相关,而基线肥胖则预示较低风险。此外,随访期间BMI的显著变化反映了进展为pADD的风险增加,无论基线时的BMI状态如何。